Level of awareness of women about HPV vaccination by age of women
Authors:
I. Gulášová 1; D. Zoľáková 2
Authors‘ workplace:
Trnavská univerzita v Trnave, Fakulta zdravotníctva a sociálnej práce, SR Katedra ošetrovateľstva, Dekan: prof. MUDr. Jaroslav Slaný, CSc.
1; Fakultná nemocnica Trnava, SR Onkologická klinika, Prednosta: MUDr. Marián Streško, PhD.
2
Published in:
Prakt. Lék. 2026; 106(2): 68-73
Category:
Of different specialties
Overview
Objective: To determine the level of awareness of women about HPV vaccination by age of women. Methods: Quantitative, descriptive study, content and relational analysis. The research group of respondents consisted of women in three age categories: 20–40 years; 41–60 years old; 61 years and older. The exclusion criterion for the selection of respondents was a healthcare professional. The obtained data were analysed according to Microsoft Office Excel 2016, statistical evaluation using the ANOVA test, which compared the arithmetic mean of the HPV vaccination awareness score according to the age of the respondents in the group we monitored, and the calculation of the P-value of the difference in the frequency of categorical variables. Results: The cohort consisted of n = 247 women, of which the largest representation was in the age category 20–40 years 66.4% women; in the age category from 41–60 years 28.3% women; in the age category over 61 years 5.3% were women. The arithmetic mean for respondents aged 20–40 years was 4.4 points (62.85%), for respondents aged 41–60 4.5 points (64.28%) and 4.3 points, i.e. (61.42%), the overall level of information is at 66.84%. Women’s awareness of HPV vaccination by age was at 63.33%; p-value = 0.8177. No statistically significant relationship was found between the age of women and the level of awareness about HPV vaccination (p = NS). Conclusion: Awareness of the importance of HPV vaccination needs to be constantly improved, new, creative ways of informing and motivating women with an emphasis on forming strong attitudes towards health by reducing the impact of cervical cancer risk factors using the EBM-based vaccination option.
Keywords:
awareness – HPV – vaccination – risk factors – EBM – female lay population
Sources
1. Alafifi R, Kindratt TB, Pagels P, et al. Awareness and knowledge of human papilloma virus and cervical cancer in women with high pap uptake. J Community Health. 2019; 44(2): 332–338.
2. Bednarczyk RA. Addressing HPV vaccine myths: practical information for healthcare providers. Hum Vaccin Immunother. 2019; 15(7–8): 1628–1638.
3. Daniels V, Prabhu VS, Palmer C, et al. Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States. Hum Vaccin Immunother. 2021; 17(7): 1943–1951.
4. de La Fuente J, Hernandez Aguado JJ, San Martín M, et al. Estimating the epidemiological impact and cost-effectiveness profile of a nonavalent HPV vaccine in Spain. Hum Vaccin Immunother. 2019; 15(7–8): 1949–1961.
5. Gerend MA, Madkins K, Crosby S, et al. Qualitative analysis of young sexual minority men’s perspectives on human papillomavirus vaccination. LGBT Health 2019; 6(7): 350–356.
6. Hong Y, Zhang C, Li X, et al. HPV and cervical cancer related knowledge, awareness and testing behaviors in a community sample of female sex workers in China. BMC Public Health 2013; 30(13): 696.
7. Chan ZC, Chan TS, Ng KK, Wong ML. A systematic review of literature about women’s knowledge and attitudes toward human papillomavirus (HPV) vaccination. Public Health Nurs. 2012; 29(6): 481–489.
8. Khatiwada M, Kartasasmita C, Mediani HS, et al. Knowledge, attitude and acceptability of the human papilloma virus vaccine and vaccination among university students in Indonesia. Front Public Health 2021; 9 : 616456. 9. Lama Y, Quinn SC, Nan X, Cruz-Cano R. Social media use and human papillomavirus awareness and knowledge among adults with children in the household: examining the role of race, ethnicity, and gender. Hum Vaccin Immunother. 2021; 17(4): 1014–1024. 10. Mandal R, Banerjee D, Gupta K, et al. Experience of human papillomavirus vaccination project in a community set up-an Indian study. Asian Pac J Cancer Prev. 2021; 22(3): 699–704.
11. McLendon L, Puckett J, Green C, et al. (2021). Factors associated with HPV vaccination initiation among United States college students. Hum Vaccin Immunother. 2021; 17(4): 1033–1043.
12. Mouková L. Nové možnosti léčby u karcinomu děložního hrdla. Onkologie 2021; 15(3): 119–122.
13. Napolitano F, Pelullo CP, Della Polla G, Angelillo IF. HPV Vaccination attitudes and behaviors among general practitioners in Italy. Vaccines (Basel) 2021; 9(1): 63.
14. Česká vakcinologická společnost ČLS JEP. Doporučení České vakcinologické společnosti ČLS JEP k očkování proti infekcím způsobených lidským papilomavirem (HPV) 2025 [online]. Dostupné z: https://www.vakcinace.eu/doporuceni-a-stanoviska/ doporuceni-ceske-vakcinologicke-spolecnosti-cls-jep-k-ockovani-proti-infekcim-zpusobenych-hpv [cit. 2026-02-23].
15. Osazuwa-Peters N, Adjei Boakye E, Mohammed KA, et al. Not just a woman’s business! Understanding men and women’s knowledge of HPV, the HPV vaccine, and HPV-associated cancers. Prev Med. 2017; 99 : 299–304.
16. Petca A, Borislavschi A, Zvanca ME, et al. Non-sexual HPV transmission and role of vaccination for a better future (Review). Exp Ther Med. 2020; 20(6): 186.
17. Petráš M, Lomozová D, Dvořák V, et al. Early and long-term effects of prophylactic and post-excision human papillomavirus vaccination on recurrent high-grade cervical intraepithelial neoplasia relative to margin status: a retrospective cohort study in the Czech Republic. Lancet Reg Health Eur. 2025; 55 : 101337.
18. Sehnal B, Rozsypal H, Nipčová M, Sláma J. Prevalence, incidence, perzistence a možnosti přenosu infekce lidským papilomavirem (HPV). Epidemiol Mikrobiol Imunol. 2017; 66(4): 198–209.
19. Shapiro GK. HPV vaccination: an underused strategy for the prevention of cancer. Curr Oncol. 2022; 29(5): 3780–3792.
20. Unger Z, Maitra A, Kohn J, et al. Knowledge of HPV and HPV vaccine among women ages 19 to 26. Womens Health Issues. 2015; 25(5): 458–462.
21. Yuanyue L, Baloch Z, Shanshan L, et al. Cervical cancer, human papillomavirus infection, and vaccine-related knowledge: awareness in Chinese women. Cancer Control. 2018; 25(1): 1073274818799306.
22. Waheed DeN, Schiller J, Stanley M, et al. Human papillomavirus vaccination in adults: impact, opportunities and challenges – a meeting report. BMC Proc. 2021; 15(Suppl 7): 16.
23. WHO. Cervical cancer 2022 [online]. Dostupné z: https:// www.who.int/news-room/fact-sheets/detail/cervical-cancer [cit. 2026-02-23].
Labels
General practitioner for children and adolescents General practitioner for adultsArticle was published in
General Practitioner
2026 Issue 2
Most read in this issue
- Is lipoprotein(a) testing relevant in cardiovascular risk stratification?
- Pokyny pro autory časopisu Praktický lékař Časopis pro další vzdělávání lékařů
- Use of modern bioanalytical methods to determine the composition of solid biological samples
- Level of awareness of women about HPV vaccination by age of women